Welcome to our dedicated page for Monroe Federal Bancorp SEC filings (Ticker: MFBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Monroe Federal Bancorp's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Monroe Federal Bancorp's regulatory disclosures and financial reporting.
Monroe Federal Bancorp, Inc. director and Chairman of the Board reported new equity awards in company stock. On December 18, 2025, the insider acquired 789 shares of common stock as an award at a stated price of $0, bringing direct ownership to 15,789 common shares. In addition, the insider reports 5,000 shares held indirectly by a spouse.
The filing also shows a new grant of stock options on 2,632 shares of common stock at an exercise price of $10.75 per share. Both the restricted stock and the options vest in equal 20% annual installments starting December 18, 2026, with the options expiring on December 18, 2035. These details outline the structure and timing of the director’s long-term incentive compensation in Monroe Federal Bancorp stock.
Monroe Federal Bancorp, Inc. reported that one of its directors acquired new equity awards on December 18, 2025. The director received 789 shares of restricted common stock at a price of $0, increasing the directly held common shares to 789. In addition, the director holds indirect common stock positions through a trust, an IRA, and a Roth IRA.
The filing also shows a grant of 2,632 stock options with an exercise price of $10.75 per share, exercisable through December 18, 2035. Both the restricted stock and these options vest at a rate of 20% per year starting on December 18, 2026, meaning the director earns these rights gradually over time.
Monroe Federal Bancorp, Inc. director reported new equity incentives in the form of restricted stock and stock options. On December 18, 2025, the reporting person acquired 789 shares of common stock as restricted stock at a stated price of $0, bringing their directly held common stock to 15,789 shares after the transaction.
The filing also shows a grant of stock options on 2,632 shares of common stock at an exercise price of $10.75 per share, dated December 18, 2025. Both the restricted shares and the options vest at a rate of 20% per year starting on December 18, 2026, which spreads the benefit of these awards over several years.
Monroe Federal Bancorp director reports new stock and option awards. A director of Monroe Federal Bancorp, Inc. received 789 shares of common stock on December 18, 2025 at a stated price of $0, increasing direct holdings to 2,289 shares. The director also holds 6,000 shares indirectly through a deferred compensation plan.
On the same date, the director was granted 2,632 stock options with an exercise price of $10.75 per share, expiring on December 18, 2035. Both the 789 restricted shares and the 2,632 options vest in installments of 20% per year starting on December 18, 2026, creating a long-term equity incentive tied to continued service.
Monroe Federal Bancorp, Inc. director reported new equity awards and updated holdings. On December 18, 2025, the director acquired 789 shares of common stock at a reported price of $0, reflected as direct ownership. The filing also shows indirect ownership of 10,000 shares through a spouse and 15,000 shares through a deferred compensation plan.
On the same date, the director received stock options for 2,632 shares with an exercise price of $10.75 per share, exercisable from December 18, 2026 and expiring on December 18, 2035. Both the restricted stock and the stock options vest at a rate of 20% per year starting on December 18, 2026, indicating a multi‑year incentive structure tied to continued service.
Monroe Federal Bancorp, Inc. reported an insider equity award to a director. On 12/18/2025, the director acquired 789 shares of common stock as an award classified as an acquisition at a price of $0 per share, bringing their directly held common stock to 15,789 shares after the transaction. The filing also shows the grant of 2,632 stock options with an exercise price of $10.75 per share, all held directly.
The restricted stock and options both vest at a rate of 20% per year starting on December 18, 2026, meaning the director’s ability to fully access these awards is spread over five years. This filing reflects routine director compensation and does not involve any sale of existing shares.
Monroe Federal Bancorp (MFBI) will hold its first annual meeting since its IPO at 3:30 p.m. on December 17, 2025 in Tipp City, Ohio. Stockholders will vote to elect three directors, approve the 2025 Equity Incentive Plan, and ratify Wipfli LLP as auditor for the year ending March 31, 2026.
The proposed 2025 Equity Incentive Plan reserves 68,436 shares, equal to 13% of the 526,438 shares sold in the conversion offering, split between 15,793 restricted stock/RSUs (3%) and 52,643 options (10%). If approved, each non‑employee director will receive a self‑executing grant of 789 restricted shares and 2,632 options that vest over five years. The closing stock price was $11.60 on October 30, 2025. As of October 31, 2025, shares outstanding were 526,438; the ESOP held 36,851 shares (7.0%). The Company’s Articles limit voting above 10% ownership. The Board recommends voting FOR all proposals.
Monroe Federal Bancorp, Inc. reported results for the quarter ended September 30, 2025. Total assets were $147.6 million, with loans receivable of $110.7 million and deposits of $122.5 million. Federal Home Loan Bank advances were $11.1 million, up from $10.0 million at March 31, 2025.
For the quarter, the company recorded a net loss of $93,503 as net interest income of $926,061, noninterest income of $141,387, and noninterest expense of $1,191,630 led to a pre‑tax loss. The allowance for credit losses was $951,939; nonaccrual loans totaled $620,941. Accumulated other comprehensive loss improved to $(3.54) million from $(4.04) million, contributing to stockholders’ equity of $12.36 million, up from $12.07 million at March 31, 2025.
For the six months ended September 30, 2025, net loss was $228,615. Cash and cash equivalents ended the period at $2.72 million, with operating cash flow of $(110,014) and net financing inflows of $2.98 million.